Kathleen R. Mulka

1 ta ish

Johns Hopkins University

1. A bacterial extracellular vesicle‐based intranasal vaccine against SARS‐CoV‐2 protects against disease and elicits neutralizing antibodies to wild‐type and Delta variants

   Linglei Jiang, Tom A. P. Driedonks, Wouter S. P. Jong +22

   Maqola20222 iqtibos

   ABIABI:AkademIndex/2026.other.452495